Hemophilia A and Hemophilia B

Inherited Bleeding Disorders in Women

Volumn , Issue , 2009, Pages 34-41

  Lee, Christine A ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Bleeding in carriers of hemophilia; Carriers of hemophilia A and B and pregnancy; Diagnosis of carriership before pregnancy; Hemophilia A and B are X linked recessive bleeding disorders; Invasive monitoring using fetal scalp electrodes and fetal blood sampling; Menorrhagia; Testing carrier status of healthy children

Indexed keywords

EID: 84889630445     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303490.ch3     Document Type: Chapter

References (41)

1. Rizza CR, Rhymes IL, Austen DEG, et al. Detection of carriers of haemophilia: a "blind" study. Br J Haematol 1975; 30: 447-456.
2. Lyon MF. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 1962; 14: 135-148.
3. Oldenburg J, Tuddenham EGT. Inhibitors to factor VIII-molecular basis In: Lee CA, Berntorp EE, Hoots WH (eds). Textbook of hemophilia. Oxford: Blackwell Science, 2005.
4. White GC, Rosendaal F, Aledort LM, et al. Definitions in haemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardisation committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
5. Nilsson IM, Blomback M, Ramgren O, von Franken I. Haemophilia in Sweden. II. Carriers of haemophilia A and B. Acta Med Scand 1962; 171: 223.
6. Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH, et al. Bleeding in carriers of hemophilia. Blood 2006; 108: 52-56.
7. Antonarakis SE, Rossiter JP, Young M, et al. Factor VIII inversions in severe haemophilia A: results of an international consortium study. Blood 1995; 86: 2206-2212.
8. Giannelli F, Green PM, Somner S. Haemophilia B. A database of point mutations and short editions and deletions. Nucleic Acids Res 1996; 24: 103-118.
9. Miller R. Genetic counselling for haemophilia. WFH treatment monograph no 25. 2002.
10. Ludlam CA, Pasi KJ, Bolton-Maggs P, et al. A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia 2005; 11: 145-163.
11. Ljund R, Petrini P, Nilsson IM. Diagnostic symptoms of severe and moderate haemophilia A and B - a survey of cases. Acta Paediatr Scand 1990; 79: 196-200.
12. Dunn NF, Miller R, Griffioen A, Lee CA. Carrier testing in haemophilia A and B: adult carriers and their partners experiences and their views on the testing of young females. Haemophilia 2008; 14: 584-592.
13. The United Nations Convention on the Rights of the Child 20. xi.1989:TS 44:Cm 1976.
14. Gillick v West Norfolk and Wisbech AHA (1986).
15. World Health Organization. Proposed international guidelines on ethical issues in medical genetics and genetic services. Geneva: World Health Organization, 1998.
16. Working Party of the Clinical Genetics Society. The genetic testing of children. J Med Genet 1994; 31: 785-797.
17. Committee on Bioethics American Academy of Pediatrics. Ethical issues with genetic testing. Pediatrics 2001; 107: 1451-1455.
18. British Medical Association. Consent, rights and choices in health care for children and young people. London: BMJ Books, 2005.
19. Borry P, Fryns J-P, Schotsmans P, Dierickx K. Carrier testing in minors: a systematic review of guidelines position papers. Eur J Hum Genet 2006; 14: 133- 138.
20. Thomas S, Herbert D, Street A, et al. Attitudes towards beliefs about genetic testing in the haemophilia community: a qualitative study. Haemophilia 2007; 13: 633-641.
21. MacLean PE, Fijnvandraat K, Beijlevelt M, Peters M. The impact of unaware carriership on the clinical presentation of haemophilia. Haemophilia 2004; 10: 560-564.
22. Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetric care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of National Haemophilia Foundation's Medical and Scientific Council. Haemophilia 1999; 5: 410-415.
23. Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40-48.
24. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss and iron deficiency. Acta Med Scand 1966; 180: 639-650.
25. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-739.
26. Mauser Bunschoten MEP, van Houwelingen JC, Sjamsoedin Visser EJM, et al. Bleeding symptoms in carriers of haemophilia A and B. Thromb Haemost 1988; 59: 349-352.
27. Falcone T, Desjardins C, Bourque J, et al. Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994; 39: 761-764.
28. Lee CA, Chi C, Pavord SR, et al. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organisation. Haemophilia 2006; 12: 301-336.
29. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-918.
30. Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104: 803-810.
31. Chi C, Lee CA, Shiltagh N, et al. Pregnancy in carriers of haemophilia. Haemophilia 2008; 14: 56-64.
32. Mannucci PM. Desmopressin in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90: 2515- 2521.
33. Chediak JR, Alban GM, Maxley B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986; 155: 618-624.
34. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998; 53: 450-455.
35. Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor-VIII deficient women. Blood 2005; 105: 3382.
36. Mannucci PM. The choice of plasma-derived clotting factor concentrates. Baillieres Clin Haematol 1996; 9: 273-290.
37. Yee TT, Cohen BJ, Pasi KJ, Lee CA. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate. Br J Haematol 1996; 93: 457-459.
38. Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with haemophilia: a review of the literature. J Pediatr Hematol Oncol 1999; 21: 289- 295.
39. Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial hemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical Scientific Advisory Council. Haemophilia 1999; 5: 410-415.
40. Ljund R, Lindgren AC, Petrini P, Tengborn L. Normal vaginal delivery is to be recommended haemophilia carrier gravidae. Acta Paediatr 1994; 83: 609-611.
41. Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. National sentinel audit report. London: RCOG Press, 2001.